Top Medical Searches

Current Medical News

UK plays catch-up with $380 million spend on cancer-zapping beams

LONDON (Reuters) – Britain’s state-run health service is to spend 250 million pounds ($382 million) on two proton beam cancer therapy centers, offering patients the opportunity to receive the modern treatment in London or Manchester from 2018. Currently, the National Health Service (NHS) sends children and adults needing proton beam therapy (PBT) to the United States, where a dozen such centers are already operational. … Read More..

July 31st, 2013

Actelion buys U.S.-based firm with cancer drug in development

ZURICH (Reuters) – Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Valchlor, to treat a form of cancer.

 Read more…

July 31st, 2013

Is This the Same Guy – an Hour Later?!

Testing the magic of lights, angles, manscaping and tanner.         Read More..

July 31st, 2013

AstraZeneca buys rights to anaemia drug from FibroGen

LONDON (Reuters) – AstraZeneca took a further step to bolster its new drug pipeline on Wednesday by striking a deal with private biotech firm FibroGen potentially worth more than $815 million for rights to an experimental anaemia drug.

 Read more…

July 31st, 2013

For surgery, big and famous hospitals aren’t always the best

NEW YORK (Reuters) – Patients going to a hospital for surgery care about many things, from how kind the nurses are to how good the food is, but Consumers Union (CU) figures what they care about most is whether they stay in the hospital longer than they should and whether they come out alive.

 Read more…

July 31st, 2013
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us